Persistence of autoantibodies directed against the beta-1-adrenoceptor in patients with heart failure after treatment with BC 007 (Rovunaptabin). Results of a phase IIa study.

BC007 - Berlin Cures

https://esc365.escardio.org/Heart-Failure/sessions/10565

M Zdravkovic1; D Kosevic2; N Markovic-Nikolic3; A Haberland4; S Becker4; E Murdfield4; P Goettel4; K Wenzel4; A Mescheder4; H-D Duengen5; E Tahirovic5; J Mueller4

May 7, 2024